Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-05-28 @ 2:04 PM
Study NCT ID:
NCT01836133
Status:
COMPLETED
Last Update Posted:
2017-05-04
First Post:
2013-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML28282
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None